Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.

Bianchi, M L; Cimaz, R; Bardare, M; Zulian, F; Lepore, L; Boncompagni, A; Galbiati, E; Corona, F; Luisetto, G; Giuntini, D; Picco, P; Brandi, M L; Falcini, F

Bianchi, M L; Cimaz, R; Bardare, M; Zulian, F; Lepore, L; Boncompagni, A; Galbiati, E; Corona, F; Luisetto, G; Giuntini, D; Picco, P; Brandi, M L; Falcini, F.

Affiliation

Bianchi ML; Università di Milano, Milan, Italy.

Arthritis Rheum ; 43(9): 1960-6, 2000 Sep.

Article in En | MEDLINE | ID: mdl-11014345

Subject(s)

Alendronate/pharmacokinetics; Connective Tissue Diseases/complications; Osteoporosis/drug therapy; Adolescent; Alendronate/therapeutic use; Body Height/drug effects; Bone Density/drug effects; Child; Child, Preschool; Female; Humans; Male; Osteoporosis/complications; Therapeutic Equivalency

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Connective Tissue Diseases / Alendronate Type of study: Clinical_trials / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Arthritis Rheum Year: 2000 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links